Olanzapine for the treatment of fibromyalgia symptoms

Journal of Pain and Symptom Management

Volumn 22, Issue 2, 2001, Pages 704-708

  Kiser, R Sanford ^a   Cohen, Howard M ^a   Freedenfeld, Robert N ^a   Jewell, Carolyn ^a   Fuchs, Perry N ^b  

^a Texas Pain Medicine Clinic   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Atypical neuroleptic; Fibromyalgia; Neuroleptic; Zyprexa

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CARISOPRODOL; CETIRIZINE; CLONAZEPAM; CYCLOBENZAPRINE; FUROSEMIDE; HALOPERIDOL; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; OLANZAPINE; OXYCODONE; PARACETAMOL; PAROXETINE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRAZODONE; ZOLPIDEM;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN; INSOMNIA; MALE; MOOD; RECURRENCE RISK; RECURRENT DISEASE; WEIGHT GAIN; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE;

EID: 0034902625     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(01)00302-5     Document Type: Article

References (27)

1. Questions and challenges in the diagnosis of fibromyalgia syndrome
2. Fibromyalgia syndrome and myofascial pain syndrome. Do they exist?
3. Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management
4. The fibromyalgia syndrome
5. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder
6. Fibromyalgia syndrome a decade later; what have we learned?
7. Treatment strategies for fibromyalgia syndrome
8. The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan
9. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study
10. Pimozide therapy for trigeminal neuralgia
11. A comparison of the analgesic effect of methotrimeprazine and morphine in patients with cancer
12. Olanzapine versus haloperidol; acute phase results of the international double-blind olanzapine trial
13. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
14. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia
15. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia
16. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome
17. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
18. Pathogenetic aspects of responsiveness to ondansetron (5- hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome-a preliminary study
19. A cost effective approach to the diagnosis and treatment of fibromyalgia
20. An open clinical trial of venlafaxine in fibromylagia
21. Role of serotonin in the pathophysiology of depression; focus on the serotonin transporter
22. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome
23. A randomized controlled trial of citalopram in the treatment of fibromyalgia
24. Serotonin and its receptors in pain control
25. Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia?
26. Do infections trigger fibromyalgia?